"The Emily Couric Clinical Cancer Center in Charlottesville, VA offers convenient access to a full range of state-of-the-art cancer treatments, all in a warm and inviting space."

During the past decade, University of Virginia Cancer Center at UV Health System conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Virginia Cancer Center at UV Health System" #1 sponsor was "National Cancer Institute (NCI)" with 2 trials, followed by "University of Virginia" with 2 trials sponsored, "Blueprint Medicines Corporation" with 1 trials sponsored, "Fox Chase Cancer Center" with 1 trials sponsored and "Gynecologic Oncology Group" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Virginia Cancer Center at UV Health System" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator and "Children's Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "University of Virginia Cancer Center at UV Health System" are "Lung Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Adoptive Cellular Immunotherapy" (1 trials), "Advanced Solid Tumor" (1 trials) and "Advanced Solid Tumors" (1 trials). Many other conditions were trialed in "University of Virginia Cancer Center at UV Health System" in a lesser frequency.

Most popular intervention types in "University of Virginia Cancer Center at UV Health System" are "Drug" (7 trials), "Procedure" (3 trials), "Biological" (2 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (3 trials), "paclitaxel" (2 trials), "radiation therapy" (2 trials), "BLU-222" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Virginia Cancer Center at UV Health System" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Virginia Cancer Center at UV Health System". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University of Virginia Cancer Center at UV Health System, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Virginia Cancer Center at UV Health System, 5 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".